The significant outperformance of Fabrinet in the market over the past 10 years, with an average annual return of 26.69%, indicates a strong and consistent growth trajectory. This historical performance, coupled with a substantial market capitalization of $7.12 billion, suggests a positive outlook for FN's stock in the short term. Investors may view this track record as a sign of the company's robust financial health and potential for continued growth.